-
Generic versions of Ozempic set to be on the Canadian market in 2026
Medical Mythbusting Commentary for July 15, 2025 Source:Canada set to get affordable Ozempic; experts warn of potential misuse
-
What are the drug interactions between the birth control pill and semaglutide (Ozempic)? Perspective is important because the interaction is no different than many other medications used with the birth control pill.
Medical Mythbusting Commentary for June 25, 2025 Source:‘Ozempic babies’ and birth control: U.K. warning raises concerns over weight-loss drugs
-
A preprint, non-peer-reviewed study states that weight-loss drugs such as Wegovy are more likely to cause temporary hair loss compared to Contrave. The latter is not overly efficacious hence less weight loss therefore less hair loss.
Medical Mythbusting Commentary for March 18, 2025 Source:Weight-Loss Drugs Like Wegovy Are Linked to Hair Loss Reference:Risk of Hair Loss with Semaglutide for Weight Loss
-
The report that scientists may have found a natural alternative to Ozempic needs to mention that it was in mice and that it is far removed from any human application.
Medical Mythbusting Commentary for January 21, 2025 Source:Scientists May Have Discovered a Natural Alternative to Ozempic Reference: https://www.nature.com/articles/s41564-024-01902-8
-
Danish studies find higher risk of optic nerve damage with Ozempic however absolute risk increase is 1 in 10,000 and biological mechanism to explain this remains elusive.
Medical Mythbusting Commentary for January 17, 2025 Source:Danish studies find higher risk of optic nerve damage with Ozempic Reference:Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes
-
House Calls, #945, November 3, 2024: When there are unexpected positive health outcomes with medication use
The recent issue of The Economist has reviewed the unexpected health benefits of Ozempic. Link is here for those who are interested in the data. Your Calls and Comments:
-
Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness. Study authors state that causality is not established. The health benefits of controlling diabetes, reduced heart, liver, kidney, and brain disease need to be considered with its use.
Medical Mythbusting Commentary for July 4, 2024 Source:Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness
-
‘Oatzempic’: TikTok Users Claim New Drink Helps With Weight Loss—Here’s What You Need to Know. This should have been an April Fools’ joke.
Medical Mythbusting Commentary for April 1, 2024 Source:‘Oatzempic’: TikTok Users Claim New Drink Helps With Weight Loss—Here’s What You Need to Know
-
Measles travel advisories, New Canadian Pharmacare not covering the cost of Ozempic for people with type 2 diabetes, and a possible new treatment pathway for people suffering from Crohn’s disease.
Medical Mythbusting Commentary for February 26, 2024 Source:Treating newly-diagnosed Crohn’s patients with advanced therapy leads to dramatic improvements in outcomes